Tampa, Florida / GlobeNewswire – Digital pathology and cancer informatics provider Inspirata announced today that it has received U.S. Food and Drug Administration (FDA) clearance for its Dynamyx digital pathology software. This clearance...

Partnership to provide access to Flagship’s AI-aided software for quantifying PD-L1 IHC stains across various tissue types NEW YORK & BROOMFIELD, Colo.--(BUSINESS WIRE)--Paige,the global leader in AI-based diagnostic software in...

Mountain View, California, February 28, 2022 – Crosscope Inc. a leading provider of AI-enabled digital pathology software and Mindpeak Gmbh, known for building sophisticated AI tools for clinical diagnosis, today announced their...

Inspirata announces new webinar. The Efficacy of AI in Matching Patients to Clinical Trials March 2nd, 4pm GMT Click Here to Learn More and Register for Webinar Inspirata cordially invites you to its upcoming webinar exploring the results...

2022/027 from 11/02/2022 - Following surgery, patients with breast cancer are faced with the question of whether additional chemotherapy is necessary and really effective. It is important that these women do not receive too much treatment –...

CU Cancer Center member Sachin Wani, MD, is leading a study to test the effectiveness of a novel diagnostic tool to improve detection of early esophageal cancer. On a mission to increase early detection of esophageal cancer, University of...